9WV logo

Nutriband DB:9WV Stock Report

Last Price

€3.84

Market Cap

€43.5m

7D

-0.5%

1Y

71.4%

Updated

23 Dec, 2024

Data

Company Financials

My Notes

Capture your thoughts, links and company narrative

Nutriband Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Nutriband
Historical stock prices
Current Share PriceUS$3.84
52 Week HighUS$8.45
52 Week LowUS$2.02
Beta0.39
1 Month Change-17.24%
3 Month Change-40.92%
1 Year Change71.43%
3 Year Change41.77%
5 Year Changen/a
Change since IPO-33.59%

Recent News & Updates

Recent updates

Shareholder Returns

9WVDE PharmaceuticalsDE Market
7D-0.5%-2.2%-2.0%
1Y71.4%-15.8%6.8%

Return vs Industry: 9WV exceeded the German Pharmaceuticals industry which returned -15.6% over the past year.

Return vs Market: 9WV exceeded the German Market which returned 6.9% over the past year.

Price Volatility

Is 9WV's price volatile compared to industry and market?
9WV volatility
9WV Average Weekly Movement13.8%
Pharmaceuticals Industry Average Movement5.4%
Market Average Movement4.9%
10% most volatile stocks in DE Market11.4%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 9WV's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: 9WV's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
2016n/aGareth Sheridanwww.nutriband.com

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company’s lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops AVERSA buprenorphine and AVERSA methylphenidate, and other transdermal pharmaceutical products.

Nutriband Inc. Fundamentals Summary

How do Nutriband's earnings and revenue compare to its market cap?
9WV fundamental statistics
Market cap€43.54m
Earnings (TTM)-€6.58m
Revenue (TTM)€1.94m

21.9x

P/S Ratio

-6.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
9WV income statement (TTM)
RevenueUS$2.02m
Cost of RevenueUS$1.38m
Gross ProfitUS$638.60k
Other ExpensesUS$7.49m
Earnings-US$6.85m

Last Reported Earnings

Oct 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.62
Gross Margin31.59%
Net Profit Margin-338.67%
Debt/Equity Ratio1.7%

How did 9WV perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 00:58
End of Day Share Price 2024/12/23 00:00
Earnings2024/10/31
Annual Earnings2024/01/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Nutriband Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Eric BederSmall Cap Consumer Research LLC
Marla MarinZacks Small-Cap Research